Guardant Share Price

Guardant Share Price

NASDAQ: GH | Large Cap | Healthcare
$145.71
+$0.50 (0.34%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Guardant Stock Performance

Open
$148.50
Prev. Close
$145.21
Circuit Range
N/A
Day Range
$145.56 - $155.96
Year Range
$74.71 - $190.69
Volume
95,709
Average Traded
$150.33

Guardant Share Price Today

As of 20 November 2026, Guardant Health, Inc.'s share price is $145.71. The stock opened at $148.50, compared to its previous close of $145.21. During today's trading session, Guardant Health, Inc.'s share price traded between $145.56 and $155.96, with an average price of $150.76. Over the past 52 weeks, the stock has recorded a high of $190.69 and a low of $74.71. In terms of performance, Guardant Health, Inc.'s share price has risen by 12.31% over the last six months and is up 34.43% on a year-on-year basis.

Guardant Share Price Chart

Line chart of the Guardant price trend over the selected period. The price rose overall, ranging from 140.41 to 148.15, ending at 145.09.
$145.56$155.96
L
Show Current Price
H

Guardant Stock Fundamentals & Key Indicators

Market Cap
$18.27B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.59
Revenue (TTM)
$982.02B
Return On Equity (TTM)
175.81%
Profit Margin
-42.39%
Debt to Equity
-5.45
Quarterly Earnings Growth YoY
3.21%

Guardant Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$281.27$301.67$334.98$360.98
Net Profit-$128.49-$112.08-$120.14-$124.36
Net Profit Margin-45.68%-37.15%-35.86%-34.45%
Income ChangeN/A12.77%-7.19%-3.51%

Guardant Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$449.54$563.95$739.02$982.02
Net Profit-$654.59-$479.45-$436.37-$416.28
Net Profit Margin-145.61%-85.02%-59.05%-42.39%
Income ChangeN/A26.76%8.99%4.60%

Guardant Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets547.61430.5439.32418.39
Current Assets1466.051055.111347.111191.59
Total Assets2013.661485.611786.421609.99
Non Current Liabilities1810.241399.671421.821356.59
Current Liabilities302.73225.58205.92193.22
Total Liabilities2112.971625.261627.741549.81
Shareholders' Equity-99.31-139.65158.6860.18

Guardant Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-184.76-239.86-324.98-313.77
Investing-627.2-261.31840.25149.82
Financing671.13-1.0477.38-184.79

About Guardant

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Guardant Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$179.00
$145.66
-18.38%
Oct 2026
$177.75
$178.46
-0.06%
Sep 2026
$157.99
$178.56
+6.02%
Aug 2026
$158.46
$168.41
+4.04%
Jul 2026
$159.69
$161.87
+7.81%
Jun 2026
$127.59
$150.14
+15.72%
May 2026
$87.91
$129.74
+48.82%
Apr 2026
$94.81
$87.18
-5.65%
Mar 2026
$92.89
$92.41
-1.65%
Feb 2026
$113.23
$93.96
-17.65%
Jan 2026
$101.98
$114.10
+11.74%
Dec 2025
$106.41
$102.11
-5.79%

Guardant Share Price FAQs